EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma

Julia Schiantarelli, Mouadh Benamar, Jihye Park, Haley E. Sax, Giacomo Oliveira, Alice Bosma-Moody, Katie M. Campbell, David Liu, Douglas B. Johnson, Scott Rodig, Catherine J. Wu, F. Stephen Hodi und 3 weitere

Cancer Cell · 2026-11

DOI: 10.1016/j.ccell.2026.10.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Julia Schiantarelli und 14 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Schiantarelli, J., Benamar, M., Park, J., Sax, H. E., Oliveira, G., Bosma-Moody, A., Campbell, K. M., Liu, D., Johnson, D. B., Rodig, S., Wu, C. J., Hodi, F. S., Ribas, A., Allen, E. V., & Haq, R. (2026). Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.10.011

Vancouver

Schiantarelli J, Benamar M, Park J, Sax HE, Oliveira G, Bosma-Moody A, et al. Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma. Cancer Cell. 2026. doi:10.1016/j.ccell.2026.10.011

BibTeX
@article{Schiantarelli2026,
  author = {Schiantarelli, Julia and Benamar, Mouadh and Park, Jihye and Sax, Haley E. and Oliveira, Giacomo and Bosma-Moody, Alice and Campbell, Katie M. and Liu, David and Johnson, Douglas B. and Rodig, Scott and Wu, Catherine J. and Hodi, F. Stephen and Ribas, Antoni and Allen, Eliezer Van and Haq, Rizwan},
  title = {Genomic mediators of acquired resistance to immunotherapy in metastatic melanoma},
  journal = {Cancer Cell},
  year = {2026},
  doi = {10.1016/j.ccell.2026.10.011}
}
Kostenlos starten →